Counseling Women with MS in Middle Age and the Postmenopausal Years
Type:
Enduring Material
Credit Hours:
1
Session Description:
As the lifespan of people with multiple sclerosis (MS) continues to expand and disease management improves, women with MS are entering their middle-age years and beyond with greater functional abilities and improved quality of life. The role of hormones and impact of menopausal changes are of concern for the clinician, as are the risk of comorbid diseases and issues relating to long-term care planning. A key question that has arisen is whether these patients should discontinue their disease-modifying therapy after a certain age, or after a long period of apparently low disease activity. The faculty panel will discuss the research evidence and real-world practice, with an emphasis on wellness and helping patients to remain functional and independent for as long as possible.
Target Audience
This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS).
Faculty
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, IL
Maria Houtchens, MD
Associate Professor, Department of Neurology
Harvard Medical School
Associate Neurologist, Director, Women's Health Program
Brigham and Women's Hospital, Boston, MA
Marie Moore, MSN, FNP-C, MSCN
Nurse Practitioner
Neurosciences Institute/Carolinas Multiple Sclerosis Center
Charlotte, NC
Distributed by
Delaware Media Group
PO Box 937, Glen Rock, NJ 07452-0937
Tel: 201-612-7676
Fax: 201-612-8282
Medical Writer/Editor
Katherine Wandersee
Art Director
James Ticchio
Disclosure Statements
Amy Perrin Ross has received consultant fees from Alexion, Biogen, Celgene, EMD Serono, Genentech, Merck, Novartis, Roche, Sanofi Genzyme, Teva, and TG Therapeutics, and has served on speakers' bureaus for Biogen, EMD Serono, Genentech, Genzyme, Novartis, and Teva.
Maria Houtchens has received consultant fees from Biogen, Celgene, EMD Serono, Genentech, Mallinckrodt, and Sanofi Genzyme.
Marie Moore has received consultant fees from Celgene, EMD Serono, and Sanofi Genzyme, and serves on a speakers' bureau for Sanofi Genzyme.
Reviewer/Nurse Planner
Laurie Scudder, DNP, NP served as Planner for this activity and has disclosed no relevant financial relationships.
The following planners and managers have disclosed no relevant financial relationships: Joseph J. D'Onofrio, Frank Marino, Katherine Wandersee.
Target Audience
This activity is designed to meet the educational needs of physicians, nurses, and advanced practice clinicians who manage patients with multiple sclerosis (MS).
Faculty
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, IL
Maria Houtchens, MD
Associate Professor, Department of Neurology
Harvard Medical School
Associate Neurologist, Director, Women's Health Program
Brigham and Women's Hospital, Boston, MA
Marie Moore, MSN, FNP-C, MSCN
Nurse Practitioner
Neurosciences Institute/Carolinas Multiple Sclerosis Center
Charlotte, NC
Distributed by
Delaware Media Group
PO Box 937, Glen Rock, NJ 07452-0937
Tel: 201-612-7676
Fax: 201-612-8282
Medical Writer/Editor
Katherine Wandersee
Art Director
James Ticchio
Disclosure Statements
Amy Perrin Ross has received consultant fees from Alexion, Biogen, Celgene, EMD Serono, Genentech, Merck, Novartis, Roche, Sanofi Genzyme, Teva, and TG Therapeutics, and has served on speakers' bureaus for Biogen, EMD Serono, Genentech, Genzyme, Novartis, and Teva.
Maria Houtchens has received consultant fees from Biogen, Celgene, EMD Serono, Genentech, Mallinckrodt, and Sanofi Genzyme.
Marie Moore has received consultant fees from Celgene, EMD Serono, and Sanofi Genzyme, and serves on a speakers' bureau for Sanofi Genzyme.
Reviewer/Nurse Planner
Laurie Scudder, DNP, NP served as Planner for this activity and has disclosed no relevant financial relationships.
The following planners and managers have disclosed no relevant financial relationships: Joseph J. D'Onofrio, Frank Marino, Katherine Wandersee.
Learning Objectives:
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for 1.0 continuing education nursing credit (1.0 in the area of pharmacology).
This webinar is supported by educational grants from Celgene and Sanofi Genzyme.
Method of Participation
Release Date: January 28, 2020
Valid for Credit Through: January 28, 2021
Follow these steps to earn CE credit:
1. Read the target audience, learning objectives, and author disclosures.
2. Study the educational content.
3. Complete the post-test and evaluation
There is no fee to participate in this educational activity.
If you have any questions about this CE activity, please contact the CMSC at education@mscare.org or 201-487-1050.
Disclosure of Unlabeled Use
This CE activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC, Delaware Media Group, and the supporters do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC, Delaware Media Group, or the supporters.
Privacy Policy
Copyright © 2019, Delaware Media Group, Inc. All rights reserved. None of the contents of this webinar program may be reproduced in any form without prior written permission. The opinions expressed in this program are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or the supporters.
- Discuss health issues affecting women with MS as they transition through peri- and postmenopausal stages.
- Analyze pros/cons of continuing disease-modifying therapy in older patients and those with secondary progressive MS.
- Adapt MS patient care and counseling approaches to meet the changing needs of aging female patients with MS
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Physicians
The CMSC designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The CMSC designates this activity for 1.0 continuing education nursing credit (1.0 in the area of pharmacology).
This webinar is supported by educational grants from Celgene and Sanofi Genzyme.
Method of Participation
Release Date: January 28, 2020
Valid for Credit Through: January 28, 2021
Follow these steps to earn CE credit:
1. Read the target audience, learning objectives, and author disclosures.
2. Study the educational content.
3. Complete the post-test and evaluation
There is no fee to participate in this educational activity.
If you have any questions about this CE activity, please contact the CMSC at education@mscare.org or 201-487-1050.
Disclosure of Unlabeled Use
This CE activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC, Delaware Media Group, and the supporters do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC, Delaware Media Group, or the supporters.
Privacy Policy
Copyright © 2019, Delaware Media Group, Inc. All rights reserved. None of the contents of this webinar program may be reproduced in any form without prior written permission. The opinions expressed in this program are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or the supporters.
Credit Types
CME: 1.00
Letter of Completion: 1.00
NCPD: 1.00
NCPD - Pharmacology: 1.00
